Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of camostat mesylate for protein-losing enteropathy after Fontan operation
KCT0007666Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of camostat mesilate in protein-losing enteropathy (PLE), sponsored by Seoul National University Hospital. Started Oct 2022; status: completed.
02
Drugs
camostat mesilate
03
Conditions
protein-losing enteropathy (PLE)
Beyond the preview
Go deeper on KCT0007666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007666.